Dr Brian A McNamee
Dr Brian A McNamee served for 23 years as the Chief Executive Officer and Managing Director of CSL Ltd from 1990 to 2013. CSL has grown to become the global leader in plasma therapeutics and key vaccines. Today CSL is a global company with a market capitalisation of approximately USD$30 billion and is publicly traded on the Australian Stock Exchange. He has extensive experience in the biotech and global health care industry and previously served as a Director of a listed US diagnostics Company GenProbe, and recently served as senior Board advisor and investor in GenesisCare, a large radiation oncology and cardiology business. Dr McNamee obtained his medical degree from the University of Melbourne. Today Dr McNamee is mainly involved in private equity and has significant interests in small cap companies through his family owned Tarnagulla Ventures. Dr McNamee is a Senior international healthcare adviser for US-based private equity firm Kohlberg Kravis Roberts [KKR], an adviser to its Australian operations and has invested in a number of KKR introduced health care opportunities. In 2009 Dr Brian McNamee was awarded the Order of Australia for his contribution to Australian business.
Natalie McNamee’s background is in Bioengineering where she attended UCSD Jacobs School of Engineering for her Masters. During Graduate school she worked at Tocagen Inc, a gene therapy company, in Business Development before working as a Bioengineer at the newly formed start up Quanticel specialising in cancer stem cell drug development. In 2015 Quanticel was acquired by Celgene for $485M. Tarnagulla Ventures was formed in 2015 where she serves as the Director of the US branch, based in San Francisco. Natalie is a Board Member on the portfolio Company, JOT Therapeutics.
William McNamee graduated with a Bachelor degree (honors) in Economics from Harvard University. Following graduation, he worked at Goldman Sachs, Inc. in New York in the Interest Rate Products Group. At the start of 2016, William joined Tarnagulla Ventures, where he serves as a Director and Portfolio Manager based in Melbourne.
TEL: +61 3 9605 9675